JI YAO HOLDING GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.51 CNY | -10.12% |
|
-15.64% | -53.54% |
| Apr. 28 | Ji Yao Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 08 | Sihuan Pharmaceutical Holdings Unit Forms Consortium for Ji Yao Restructuring | MT |
| Sales 2022 | 489M 67.49M | Sales 2023 | 346M 47.78M | Capitalization | 2.16B 299M |
|---|---|---|---|---|---|
| Net income 2022 | -276M -38.1M | Net income 2023 | -349M -48.18M | EV / Sales 2022 | 6.01 x |
| Net Debt 2022 | 1.65B 227M | Net Debt 2023 | 1.62B 224M | EV / Sales 2023 | 10.9 x |
| P/E ratio 2022 |
-4.69
x | P/E ratio 2023 |
-6.2
x | Employees | 1,065 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.79% |
More Fundamentals
* Assessed data
More news
| 1 day | -10.12% | ||
| 1 week | -15.64% | ||
| Current month | -9.04% | ||
| 1 month | -19.25% | ||
| 3 months | -39.60% | ||
| 6 months | -56.36% | ||
| Current year | -53.54% |
1 week
1.51
1.79
1 month
1.512.04
Current year
1.513.45
1 year
1.514.07
3 years
1.445.58
5 years
1.446.53
10 years
1.4417.47
| Managers | Title | Age | Since |
|---|---|---|---|
Zheng Fa Lu
CEO | Chief Executive Officer | 34 | 22-06-07 |
Zhong Wei Zhang
DFI | Director of Finance/CFO | 46 | 17-10-12 |
Chong En Du
CTO | Chief Tech/Sci/R&D Officer | 85 | 07-12-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Yu
BRD | Director/Board Member | 53 | 22-06-07 |
Li Yun Zhang
BRD | Director/Board Member | 36 | 22-06-07 |
Ke Li You
PRN | Corporate Officer/Principal | 66 | 07-12-15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-05 | 1.51 | -10.12% | 12 304 050 |
| 24-06-05 | 1.68 | +3.70% | 13,247,050 |
| 24-06-04 | 1.62 | +1.25% | 6,917,250 |
| 24-06-03 | 1.6 | -3.61% | 10,574,450 |
| 24-05-31 | 1.66 | -4.60% | 12,908,700 |
End-of-day quote Shenzhen S.E., June 05, 2024
More quotes
Ji Yao Holding Group Co., Ltd., formerly Tong Hua Shuang Long Chemical Industry Co., LTD., is a China-based company principally engaged in the research, development, production and sales of drugs. The Company's main products include Zhitong Huazheng Jiaonang (analgesic capsules), Reduping Keli (granules for cold) and Tongluo Zhitong medicinal liquor. The Company is also involved in the production, manufacture and sale of fine chemicals. The Company distributes its products in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -53.54% | 154M | |
| +16.93% | 42.79B | |
| +22.20% | 22.81B | |
| +16.96% | 15.04B | |
| +18.51% | 14.49B | |
| +51.63% | 12.65B | |
| -0.05% | 6.79B | |
| -11.45% | 6.74B | |
| -8.87% | 5.73B | |
| +14.27% | 5.47B |
- Stock Market
- Equities
- 300108 Stock
